
Opinion|Videos|February 5, 2024
How to Address Increasing Neurofilament Light Chain Levels
Tanuja Chitnis, MD, shares possible course of action if NFL levels begin to rise during treatment.
Advertisement
Episodes in this series

Tanuja Chitnis, MD, expresses a preference for conducting an MRI and personally examining the patient to gather a comprehensive understanding of the situation. She emphasizes the need to identify potential asymptomatic new changes on the neurological exam. Additionally, she acknowledges that the level of comfort and confidence in interpreting NFL changes may evolve in the future.
Video synopsis is AI-generated and reviewed by HCPLive® editorial staff.
This program is supported by Novartis Pharmaceuticals Corporation. Content is independently developed by CMSC.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Key Neurology Trial Readouts to Watch in Early 2026
2
BMB-101 Heads for Registrational Trials Following Positive Phase 2 Data in Absence Seizures, Developmental Encephalopathies
3
Inside the 2026 MDA Conference: Emerging Research Themes in Neuromuscular Medicine
4
Annexon Submits Marketing Authorization Application for Tanruprubart to Treat Guillain-Barré Syndrome
5




























